Clinical Trials Directory

Trials / Completed

CompletedNCT03997617

Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg.

Pilot Study to Explore the Integrated Personalized Functional Profiling (PFP) for Cancer Patients With Metastatic Gastrointestinal Cancer (mGIC) or Recurrent Glioblastoma (rGBM) in Luxembourg

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Luxembourg Institute of Health · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators are developing a novel standardized and centralized approach named Integrated Personalized Functional Profiling (PFP) in Luxembourg. Based on recent improvements in cancer biopsy-derived 3D-culture technologies the PFP process will screen patient derived cells (PDCs) with FDA/EMA-approved drugs to generate personalized functional response profiles. The selected drug through PFP technology will provide personalized treatment recommendation for the patient. This pilot study will evaluate the clinical feasibility of setting-up an effective workflow as a first step. Outcomes from this study will be used subsequently to help plan the clinical validation of the implementation of PFP.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPersonalized Functional ProfilingDuring this pilot study, the overall goal of the project is to establish an effective workflow between the patient, the PFP platform, the clinician and return to the patient. This includes collection of the biopsy or surgery piece and standardized processing, dissociation, drug profiling and issuing treatment recommendation to the clinician. In case the clinician follows this treatment recommendation, patient management and follow up will be performed according to standard of care.

Timeline

Start date
2019-03-11
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2019-06-25
Last updated
2025-06-13

Locations

2 sites across 1 country: Luxembourg

Source: ClinicalTrials.gov record NCT03997617. Inclusion in this directory is not an endorsement.